| |
| |
|
| Insider
Information: |
Detheux Michel |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
58,903 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
58,903 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iteos Therapeutics, Inc. |
ITOS |
|
2023-12-05 |
58,903 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive OfficerOfficer |
• • – |
2020-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
177,937 |
|
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-11-01 |
4 |
AS |
$28.00 |
$2,268 |
D/D |
(81) |
96,913 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-10-21 |
4 |
AS |
$28.00 |
$5,488 |
D/D |
(196) |
96,994 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-10-19 |
4 |
AS |
$28.00 |
$5,628 |
D/D |
(201) |
97,190 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-08-24 |
4 |
AS |
$28.26 |
$6,359 |
D/D |
(225) |
141,213 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-08-25 |
4 |
AS |
$28.00 |
$24,109 |
D/D |
(861) |
140,352 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-09-24 |
4 |
AS |
$28.02 |
$30,512 |
D/D |
(1,089) |
99,026 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-10-15 |
4 |
AS |
$28.01 |
$45,796 |
D/D |
(1,635) |
97,391 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-12-22 |
4 |
OE |
$4.30 |
$7,151 |
D/D |
1,663 |
79,863 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-08-30 |
4 |
AS |
$28.01 |
$65,039 |
D/D |
(2,322) |
129,782 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-08-31 |
4 |
AS |
$28.12 |
$115,095 |
D/D |
(4,093) |
125,689 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-09-23 |
4 |
AS |
$28.16 |
$149,862 |
D/D |
(5,322) |
100,115 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-11-03 |
4 |
AS |
$28.89 |
$175,777 |
D/D |
(6,085) |
76,437 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-08-23 |
4 |
AS |
$28.06 |
$210,422 |
D/D |
(7,499) |
141,438 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-08-27 |
4 |
AS |
$28.17 |
$232,346 |
D/D |
(8,248) |
132,104 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-09-01 |
4 |
AS |
$28.30 |
$245,722 |
D/D |
(8,684) |
117,005 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-12-20 |
4 |
OE |
$4.30 |
$39,177 |
D/D |
9,111 |
87,311 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-12-20 |
4 |
AS |
$43.94 |
$400,337 |
D/D |
(9,111) |
78,200 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2022-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
44,700 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2022-04-18 |
4 |
S |
$31.87 |
$366,530 |
D/D |
(11,500) |
26,263 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2022-04-18 |
4 |
OE |
$4.23 |
$48,645 |
D/D |
11,500 |
37,763 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-09-02 |
4 |
AS |
$28.91 |
$334,796 |
D/D |
(11,568) |
105,437 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-11-02 |
4 |
AS |
$28.42 |
$408,920 |
D/D |
(14,391) |
82,522 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2021-11-23 |
4 |
AS |
$36.08 |
$523,160 |
D/D |
(14,500) |
78,200 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2022-01-25 |
4 |
AS |
$35.45 |
$517,378 |
D/D |
(14,500) |
49,200 |
0 |
- |
|
32 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
